The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Implementing a high-reliability, system-wide program for pre-emptive DPD deficiency testing for patients planned for a systemic fluoropyrimidine.
 
Garrett Rompelman
Stock and Other Ownership Interests - 3M; Amgen; ATAI Life Sciences; Compass Pathways Inc.; Crispr Therapeutics; Cybin; Genmab; MindMed
 
Jennifer Espiritu
No Relationships to Disclose
 
Angela Chen
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - AstraZeneca
 
Jennifer A. Chan
Stock and Other Ownership Interests - Merck
Honoraria - Ipsen
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer (I); Curium Pharma; Ipsen; Novartis; Pfizer (I); TerSera
Research Funding - Lilly (Inst); Sanofi (Inst)
(OPTIONAL) Uncompensated Relationships - Camurus
 
Caroline Cole Block
No Relationships to Disclose
 
Douglas Adam Rubinson
Consulting or Advisory Role - Augmenix; Axial Therapeutics; Boston Scientific; Instylla
Patents, Royalties, Other Intellectual Property - Royalty payments related to lentiviral shRNA technology invented in 2003
 
Joseph Jacobson
No Relationships to Disclose